Assignee profile:

Servier Pharmaceuticals LLC

City:

Boston, Massachusetts

Country:

United States

Published Applications:

23

Last publication date:

2026-03-26

Patent Grants:

20

Last grant date:

2025-10-07

Top Inventors for applications by Servier Pharmaceuticals LLC

These are the the leading inventors for applications assigned to Servier Pharmaceuticals LLC:

Recent patent applications by Servier Pharmaceuticals LLC

Servier Pharmaceuticals LLC based in Boston, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2026-03-26
US20260085059A1
Chemistry; metallurgy

THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE

#2 | 2024-10-10 ✅ Patent 12,433,895 granted on 2025-10-07
US20240335448A1
Human necessities

THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE

#3 | 2024-05-09 ✅ Patent 12,290,508 granted on 2025-05-06
US20240148697A1
Human necessities

Methods of use for trisubstituted benzotriazole derivatives

#4 | 2024-02-08 ✅ Patent 12,303,512 granted on 2025-05-20
US20240041892A1
Human necessities

Therapeutically active compounds and their methods of use

#5 | 2023-10-12 ✅ Patent 11,865,079 granted on 2024-01-09
US20230321107A1
Human necessities

Therapeutically active compounds and their methods of use

#6 | 2023-09-14
US20230285365A1
Human necessities

USE OF A DHODH INHIBITOR COMPOUND IN COMBINATION CANCER THERAPY

#7 | 2023-01-26 ✅ Patent 12,479,824 granted on 2025-11-25
US20230025411A1
Chemistry; metallurgy

A METHOD FOR PREPARING IVOSIDENIB AND AN INTERMEDIATE THEREOF

#8 | 2022-11-17 ✅ Patent 11,851,417 granted on 2023-12-26
US20220363661A1
Chemistry; metallurgy

Cocrystals, pharmaceutical compositions thereof, and methods of treatment involving same

#9 | 2022-11-17 ✅ Patent 12,064,436 granted on 2024-08-20
US20220362250A1
Human necessities

Methods of treating brain tumors using combination therapy

#10 | 2022-11-10 ✅ Patent 11,844,758 granted on 2023-12-19
US20220354856A1
Human necessities

Therapeutically active compounds and their methods of use

#11 | 2022-11-03 ✅ Patent 11,505,538 granted on 2022-11-22
US20220348554A1
Chemistry; metallurgy

Therapeutically active compounds and their methods of use

#12 | 2022-06-02
US20220169654A1
Chemistry; metallurgy

New Organic Compounds

#13 | 2022-05-10 ✅ Patent 11,325,914 granted on 2022-05-10
US17000411
Chemistry; metallurgy

Inhibitors of cellular metabolic processes

#14 | 2022-02-24 ✅ Patent 12,297,179 granted on 2025-05-13
US20220055995A1
Chemistry; metallurgy

Crystalline and salt forms of an organic compound and pharmaceutical compositions thereof

#15 | 2021-10-21 ✅ Patent 12,264,148 granted on 2025-04-01
US20210323944A1
Chemistry; metallurgy

Ivosidenib forms and pharmaceutical compositions

#16 | 2021-07-01 ✅ Patent 11,345,677 granted on 2022-05-31
US20210198234A1
Chemistry; metallurgy

Cocrystals, pharmaceutical compositions thereof, and methods of treatment involving same

#17 | 2021-04-22 ✅ Patent 11,524,960 granted on 2022-12-13
US20210115045A1
Chemistry; metallurgy

Heterobicyclic inhibitors of MAT2A and methods of use for treating cancer

#18 | 2021-04-22 ✅ Patent 11,717,512 granted on 2023-08-08
US20210113531A1
Human necessities

Methods of use for trisubstituted benzotriazole derivatives

#19 | 2021-02-18 ✅ Patent 12,042,497 granted on 2024-07-23
US20210046081A1
Human necessities

Methods of treating brain tumors using combination therapy

#20 | 2021-01-28 ✅ Patent 11,667,673 granted on 2023-06-06
US20210024575A1
Chemistry; metallurgy

Therapeutically active compounds and their methods of use

#21 | 2020-12-24 ✅ Patent 11,504,361 granted on 2022-11-22
US20200397768A1
Human necessities

Pharmaceutical compositions of therapeutically active compounds

#22 | 2018-10-25 ✅ Patent 11,419,859 granted on 2022-08-23
US20180303808A1
Human necessities

Combination therapy for treating malignancies

#23 | 2018-03-08 ✅ Patent 11,389,454 granted on 2022-07-19
US20180064715A1
Human necessities

Tablet compositions

Also check out Servier Pharmaceuticals LLC's (Boston, United States) applicant profile with 29 patent applications submitted.

AssigneeID:

324395 ⎘